SE7613971L - Forfarande for framstellning av porosa tabletter - Google Patents

Forfarande for framstellning av porosa tabletter

Info

Publication number
SE7613971L
SE7613971L SE7613971A SE7613971A SE7613971L SE 7613971 L SE7613971 L SE 7613971L SE 7613971 A SE7613971 A SE 7613971A SE 7613971 A SE7613971 A SE 7613971A SE 7613971 L SE7613971 L SE 7613971L
Authority
SE
Sweden
Prior art keywords
solvent
tablets
mixture
porosa
preparing
Prior art date
Application number
SE7613971A
Other languages
Unknown language ( )
English (en)
Other versions
SE423967B (sv
Inventor
K-W Knitsch
A Hagen
E Munz
H Determann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7613971L publication Critical patent/SE7613971L/sv
Publication of SE423967B publication Critical patent/SE423967B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7613971A 1975-12-16 1976-12-13 Forfarande for framstellning av porosa tabletter SE423967B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2556561A DE2556561C2 (de) 1975-12-16 1975-12-16 Verfahren zur Herstellung von porösen Tabletten

Publications (2)

Publication Number Publication Date
SE7613971L true SE7613971L (sv) 1977-06-17
SE423967B SE423967B (sv) 1982-06-21

Family

ID=5964516

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613971A SE423967B (sv) 1975-12-16 1976-12-13 Forfarande for framstellning av porosa tabletter

Country Status (13)

Country Link
US (1) US4134943A (sv)
JP (2) JPS5276420A (sv)
AT (1) AT348133B (sv)
BE (1) BE849438A (sv)
CH (1) CH609563A5 (sv)
DE (1) DE2556561C2 (sv)
FR (1) FR2335205A2 (sv)
GB (1) GB1502580A (sv)
IE (1) IE44571B1 (sv)
IT (1) IT1124797B (sv)
NL (1) NL7613818A (sv)
SE (1) SE423967B (sv)
SU (1) SU719480A3 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CH637014A5 (de) * 1978-09-29 1983-07-15 Sandoz Ag Verfahren zur herstellung von suppositorien.
HU179442B (en) * 1978-10-30 1982-10-28 Chinoin Gyogyszer Es Vegyeszet Process and equipment for preparing tablets
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
US5030203A (en) * 1987-11-16 1991-07-09 Baxter International Inc. Ampule for controlled administration of beneficial agent
ATE99546T1 (de) * 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
ATE138563T1 (de) * 1991-12-20 1996-06-15 Pfizer Poröse geformte abgabevorrichtung und verfahren zur herstellung derselbe
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
ATE216577T1 (de) * 1992-01-29 2002-05-15 Takeda Chemical Industries Ltd Schnellösliche tablette und ihre herstellung
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB2328154B (en) * 1997-09-03 1999-06-23 Asoka Malinga Ratwatte Hiran A method of tabletting comprising forming a mixture, containing active agent & free-flowing ice particles, into a tablet & removing the ice from the tablet
US20040265377A1 (en) * 1997-10-27 2004-12-30 Harry Seager Solid dispersing vaccine composition for oral delivery
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
AR032556A1 (es) * 2001-02-08 2003-11-12 Pharmacia Corp Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
EP1432410A2 (en) * 2001-09-25 2004-06-30 Ranbaxy Laboratories, Ltd. Process for the preparation of fast dissolving effervescent dosage form
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
AU2002346305A1 (en) * 2002-06-20 2004-01-06 Kansai Koso Co., Ltd. Process for producing solid bath additive containing shape-retaining matter and humidifying/cooling apparatus
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
EP1545521A2 (en) * 2002-10-04 2005-06-29 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
JP2006507298A (ja) * 2002-10-30 2006-03-02 ファルマシア コーポレーション 経口持続放出型錠剤、ならびにその製造法および使用法
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
BRPI0512933B8 (pt) * 2004-06-30 2021-05-25 Dsm Ip Assets Bv grânulos compactados por rolo compreendendo antibiótico de (beta) - lactama e processo para preparação dos ditos grânulos
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
CN101686942B (zh) * 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
WO2011086194A1 (en) * 2010-01-18 2011-07-21 Cephalon France Improved oral lysophilisates containing pvp/va
CN103402497A (zh) 2010-12-02 2013-11-20 阿普塔利斯医药科技公司 快速分散颗粒、口腔崩解片以及方法
JP5701971B2 (ja) * 2011-03-04 2015-04-15 株式会社クレハ 錠剤型の経口投与用組成物及びその製造方法
US8192659B1 (en) 2011-09-12 2012-06-05 On Demand Therapeutics, Inc. Methods of making microtablets for drug delivery
PL2719373T3 (pl) 2012-10-12 2017-10-31 Omya Int Ag Preparat szybko rozpadającej się stałej postaci dawkowanej zawierający funkcjonalizowany węglan wapnia i sposób ich wytwarzania
JP6659591B2 (ja) 2014-06-09 2020-03-04 テルモ ビーシーティー、インコーポレーテッド 凍結乾燥
US10793327B2 (en) 2017-10-09 2020-10-06 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
CA3130670A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877159A (en) * 1957-04-26 1959-03-10 Ciba Pharm Prod Inc Method for preparing tablet granulations
US3607753A (en) * 1967-11-16 1971-09-21 Us Army Method of making lithium ferrite powders
US3812224A (en) * 1969-05-05 1974-05-21 Polysar Ltd Process for the production of porous polymeric materials
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten

Also Published As

Publication number Publication date
AT348133B (de) 1979-01-25
BE849438A (fr) 1977-06-15
JPS56120617A (en) 1981-09-22
IT1124797B (it) 1986-05-14
FR2335205B1 (sv) 1981-05-29
CH609563A5 (sv) 1979-03-15
SU719480A3 (ru) 1980-02-29
DE2556561A1 (de) 1977-06-30
SE423967B (sv) 1982-06-21
IE44571B1 (en) 1982-01-13
DE2556561C2 (de) 1983-04-14
JPS5276420A (en) 1977-06-27
GB1502580A (en) 1978-03-01
IE44571L (en) 1977-06-16
NL7613818A (nl) 1977-06-20
FR2335205A2 (fr) 1977-07-15
US4134943A (en) 1979-01-16
ATA927076A (de) 1978-06-15
JPS5824410B2 (ja) 1983-05-20

Similar Documents

Publication Publication Date Title
SE7613971L (sv) Forfarande for framstellning av porosa tabletter
ES473459A1 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes
GB1487186A (en) Temperature indicating compositions
SE429341B (sv) Forfarande for separering och atervinning av furfural och organiska flyktiga syror, sasom ettiksyra och myrsyra, vid furfuralframstellningsprocessen
JPS53116348A (en) Stereospecific cyclization of d-citronellal to 1-isopulegol
Soai et al. EFFECTS OF SOLVENTS ON THE ENANTIOFACE-DIFFERENTIATING (ASYMMETRIC) ADDITION OF BUTYLLITHIUM TO BENZALDEHYDE USING (2 S, 2′ S)-2-HYDROXYMETHYL-1-[(1-METHYLPYRROLIDIN-2-YL) METHYL] PYRROLIDINE AS A CHIRAL LIGAND
JPS5331639A (en) Preparation of benzyl benzoate
JPS543893A (en) Purification of polymeric material-containing liquid
JPS53127891A (en) Crystallization of co-enzyme q
JPS53130054A (en) Orientation treatment method of liquid crystal cells
JPS5214739A (en) Process for recovery of terephthalic acid
ES431232A1 (es) Procedimiento y dispositivo para la obtencion y la acumula-cion de frigorias en un liquido tal como el agua.
JPS5239638A (en) Process for preparation of decabromobiphenylether
JPS52156846A (en) Preparation of cyanonorbornene
JPS5392886A (en) Preparation of hydroxyl-terminated liquid chloroprene polymer
JPS5359622A (en) Preparation of saccharic acid salt mixture
JPS5219364A (en) Breaking method of low temperature brittle
JPS5356616A (en) Preparation of sulfoalkyl maleate-type anionic sulfoalkyl
GB1018853A (en) Method for preparing alkali metal pyrrolidones
GB647433A (en) Production of dichlorodiphenyltrichloroethane
JPS5334758A (en) Preparation of alpha-(n-silyl-n-substituted)-carbamoylcarboxylic acid esters
JPS5432414A (en) Preparation of organic acid ester
JPS5268171A (en) Preparation of substituted ethyleneimines
ES332888A1 (es) Procedimiento para obtener un cuerpo solidificado microporoso.
JPS51151867A (en) Solid liquid separator

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7613971-6

Effective date: 19901019

Format of ref document f/p: F